No Change of Sleep after 6 and 12 months of methadone maintenance treatment

Journal of Addiction Medicine

Volumn 5, Issue 2, 2011, Pages 141-147

  Peles, Einat ^a,b   Schreiber, Shaul ^a,b   Bar Hamburger, Rachel ^c   Adelson, Miriam ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Israel Anti Drug Authority   (Israel)

Author keywords

Benzodiazepines; Body mass index; Methadone maintenance treatment; Obstructive apnea; Polysomnography; Prospective followup; Sleep improvement

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE; BENZOYLECGONINE; CANNABIS; METHADONE; OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CENTRAL SLEEP APNEA SYNDROME; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; ENZYME IMMUNOASSAY; EPWORTH SLEEPINESS SCALE; EYE MOVEMENT; FEMALE; HUMAN; LATENT PERIOD; MALE; METHADONE TREATMENT; OPIATE ADDICTION; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; SLEEP PATTERN; SLEEP QUALITY; URINALYSIS; WEIGHT GAIN; AGED; DRUG EFFECT; FOLLOW UP; ISRAEL; MIDDLE AGED; SLEEP; SLEEP STAGE;

ADULT; AGED; ANALGESICS, OPIOID; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP; SLEEP STAGES; YOUNG ADULT;

EID: 80052185725     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3181e8b6c4     Document Type: Article

References (37)

1. Aldrich MS. Effects of alcohol on sleep. In: Lisansky Gomberg ES, et al, eds. Alcohol Problems and Aging. Bethesda, MD: NIAAA. In press.
2. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurements techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-689.
3. Auerbach S. Sleep Disorders Related Alcohol and Other Drug Use, in Graham, Schultz, Mayo-Smith, Ries &Wilford. Principle of Addiction Medicine. 3rd ed. Chevy Chase, MD: ASAM, 2003.
4. Berger G, Berger R, Oksenberg A. Progression of snoring and obstructive sleep apnoea: The role of increasing weight and time. Eur Respir J 2009;33:338-345.
5. Blum K, Chen AL, Braverman ER, et al. Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 2008;4:893-918.
6. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
7. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3:235-241.
8. Farney RJ, Walker JM, Cloward TV, et al. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003;123:632-639. (Pubitemid 36269457)
9. Feinberg I, Fein G, Walker JM, et al. Flurazepam effects on sleep EEG: Visual, computer and cycle analysis. Arch Gen Psychiatry 1979;36:95-102. (Pubitemid 10187554)
10. Hawks RL. Analytical methodology. NIDA Res Monogr 1986;73:30-42.
11. Hemmeter U, Kocher R, Ladewig D, et al. EMG abnormalities in REM sleep of addicted patients. Ther Umsch 1993;50:169-177. (Pubitemid 23135164)
12. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991;14:540-545.
13. Kay DC, Pickworth WB, Neider GL. Morphine-like insomnia from heroin in nondependent human addicts. Br J Clin Pharmacol 1981; 11:159-169. (Pubitemid 11167983)
14. McLellan AT, Luborsky L, O'Brien CP, et al. The Addiction Severity Index in three different populations. NIDA Res Monogr 1984;55:217-223. (Pubitemid 15024150)
15. Mitler MM. Nonselective and selective benzodiazepine receptor agonists- Where are we today? Sleep 2000;23:S39-S47.
16. Nocjar C, Panksepp J. Prior morphine experience induces long-term increases in social interest and in appetitive behavior for natural reward. Behav Brain Res 2007;181:191-199. (Pubitemid 46908753)
17. Okruhlica L, Slezáková S. Weight gain among the patients in methadone maintenance program as come-back to population norm. Cas Lek Cesk 2008;147:426-430.
18. Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 2006;82:103-110.
19. Peles E, Schreiber S, Adelson M. Documented poor sleep among methadonemaintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol 2009; 19:581-588.
20. Peles E, Schreiber S, Gordon J, et al. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 2005;113:340-346. (Pubitemid 40127516)
21. Peles E, Schreiber S, Sason A, et al. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment (MMT) program. J Addict Med 2011;5:92-98.
22. Rajs J, Petersson A, Thiblin I, et al. Nutritional status of deceased illicit drug addicts in Stockholm, Sweden-A longitudinal medicolegal study. J Forensic Sci 2004;49:320-329. (Pubitemid 38298459)
23. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: BIS/BRI, UCLA, 1968.
24. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003;289:2370-2378. (Pubitemid 37430169)
25. Schierenbeck T, Riemann D, Berger M, et al. Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana. Sleep Med Rev 2008;12:381-389.
26. Sharkey KM, Kurth ME, Anderson BJ, et al. Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. Drug Alcohol Depend 2010;108:77-83.
27. Sharkey KM, Kurth ME, Corso RM, et al. Home polysomnography in methadone maintenance patients with subjective sleep complaints. Am J Drug Alcohol Abuse 2009;35:178-182.
28. Shochat T, Tzischinsky O, Oksenberg A, et al. Validation of the Pittsburgh Sleep Quality Index Hebrew translation (PSQI-H) in a sleep clinic sample. Isr Med Assoc J 2007;9:853-856.
29. Staedt J, Wassmuth F, Stoppe G, et al. Effects of chronic treatment with methadone and naltrexone on sleep in addicts. Eur Arch Psychiatry Clin Neurosci 1996;246:305-309. (Pubitemid 26340818)
30. Stein MD, Herman DS, Bishop S, et al. Sleep disturbances among methadone maintained patients. J Subst Abuse Treat 2004;26:175-180. (Pubitemid 38452836)
31. Stone AA, Broderick JE, Porter LS, et al. The experience of rheumatoid arthritis pain and fatigue: Examining momentary reports and correlates over one week. Arthritis Care Res 1997;10:185-193. (Pubitemid 27279751)
32. Teichtahl H, Prodromidis A, Miller B, et al. Sleep-disordered breathing in stable methadone programme patients: A pilot study. Addiction 2001; 96:395-403. (Pubitemid 32217480)
33. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007;3:455-461. (Pubitemid 47378247)
34. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348-1356. (Pubitemid 41324417)
35. Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007;11:35-46. (Pubitemid 46096783)
36. Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9:425-432. (Pubitemid 351722516)
37. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235. (Pubitemid 23115702)